About Tassos Nicolaou

This author has not yet filled in any details.
So far Tassos Nicolaou has created 4 blog entries.

Delpor Announces First Patient Dosed in Phase 1b/2a Clinical Trial of Once-Yearly Risperidone Implant

If approved, Delpor’s risperidone implant will be the first once-yearly schizophrenia maintenance therapy. BRISBANE, CA, April 22, 2021 — Delpor, Inc. (Delpor), a clinical-stage biopharmaceutical company that utilizes innovative technologies in order to develop once-yearly [...]

By |2021-11-16T19:17:52+00:00April 22nd, 2021|News|0 Comments

Delpor to Tackle Opioid Use Disorder with $5.7 million NIH HEAL Grant Award for the Development of a Once-Yearly Naltrexone Therapy to Prevent Relapses

Company to expand the use of its PROZOR implant technology by building on the success with its lead antipsychotic program Upon successful completion of the grant’s initial phase, Delpor may receive additional funding in order [...]

By |2019-10-09T23:02:32+00:00October 9th, 2019|News|0 Comments
Go to Top